Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Steven Madden
SHOO
$3.44B
| $7.36M | ﹤0.01% |
298,003
-139,626
| -32% | -$3.27M |
|
2427
Campbell Soup
CPB
$6.91B
| $7.33M | ﹤0.01% |
147,767
-754,542
| -84% | -$37.5M |
|
|
HUYA
2428
PUT
Huya Inc
HUYA
$531M
| $7.33M | ﹤0.01% |
392,600
-32,300
| -8% | -$539K |
|
2429
Reinsurance Group of America
RGA
$16.3B
| $7.31M | ﹤0.01% |
93,229
-55,342
| -37% | -$5.11M |
|
2430
PUT
Nutanix
NTNX
$18B
| $7.3M | ﹤0.01% |
308,000
-21,700
| -7% | -$449K |
|
|
JPXN
2431
iShares JPX-Nikkei 400 ETF
JPXN
$142M
| $7.28M | ﹤0.01% |
122,575
+38,540
| +46% | +$2.21M |
|
2432
Installed Building Products
IBP
$6.42B
| $7.28M | ﹤0.01% |
105,824
-36,297
| -26% | -$2.01M |
|
2433
PUT
CRISPR Therapeutics
CRSP
$5.15B
| $7.28M | ﹤0.01% |
99,000
+15,800
| +19% | +$924K |
|
2434
CALL
Dave & Buster's
PLAY
$351M
| $7.27M | ﹤0.01% |
545,600
+363,800
| +200% | +$4.85M |
|
|
BLU
2435
DELISTED
BELLUS Health Inc.
BLU
| $7.27M | ﹤0.01% |
704,616
+112,534
| +19% | +$1.14M |
|
2436
CALL
Equitable Holdings
EQH
$14.4B
| $7.26M | ﹤0.01% |
376,500
+366,400
| +3,628% | +$6.55M |
|
|
AMRN
2437
CALL
Amarin Corp
AMRN
$296M
| $7.26M | ﹤0.01% |
52,470
-13,670
| -21% | -$1.88M |
|
2438
PUT
Arrowhead Research
ARWR
$12.3B
| $7.26M | ﹤0.01% |
168,100
+18,600
| +12% | +$656K |
|
|
PDLI
2439
DELISTED
PDL BioPharma, Inc.
PDLI
| $7.26M | ﹤0.01% |
2,493,332
-690,346
| -22% | -$2.18M |
|
2440
CALL
ProShares Short S&P500
SH
$841M
| $7.25M | ﹤0.01% |
81,075
+43,125
| +114% | +$4.14M |
|
|
ZGNX
2441
PUT
DELISTED
Zogenix, Inc.
ZGNX
| $7.25M | ﹤0.01% |
268,300
+184,900
| +222% | +$5.1M |
|
|
IPHI
2442
CALL
DELISTED
INPHI CORPORATION
IPHI
| $7.24M | ﹤0.01% |
61,600
-30,800
| -33% | -$3.24M |
|
2443
Columbia Diversified Fixed Income Allocation ETF
DIAL
$388M
| $7.24M | ﹤0.01% |
342,643
+278,077
| +431% | +$5.75M |
|
2444
iShares US Healthcare ETF
IYH
$3.75B
| $7.23M | ﹤0.01% |
167,685
+86,180
| +106% | +$3.64M |
|
2445
PUT
Molina Healthcare
MOH
$11.1B
| $7.23M | ﹤0.01% |
40,600
+4,400
| +12% | +$749K |
|
2446
ACI Worldwide
ACIW
$5.38B
| $7.22M | ﹤0.01% |
267,626
-143,663
| -35% | -$3.76M |
|
2447
Chemours
CC
$2.36B
| $7.22M | ﹤0.01% |
470,549
-742,238
| -61% | -$9.38M |
|
2448
IDEX
IEX
$17.6B
| $7.22M | ﹤0.01% |
45,692
-127,759
| -74% | -$19.5M |
|
2449
Arthur J. Gallagher & Co
AJG
$64.6B
| $7.22M | ﹤0.01% |
74,053
-741,147
| -91% | -$65.6M |
|
2450
Gerdau
GGB
$9.24B
| $7.22M | ﹤0.01% |
3,072,969
+1,043,003
| +51% | +$1.98M |
|
Similar funds
Citadel Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Citadel Advisors held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Citadel Advisors opened a new position in Becton Dickinson worth $266M.
- Citadel Advisors's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Citadel Advisors added most to Amazon in Q2 2020, an estimated $861M increase.
- Citadel Advisors's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Citadel Advisors fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Citadel Advisors's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Citadel Advisors opened 1,506 new positions and closed 1,324 in Q2 2020.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.